President’s Forum 2022: University on growth trajectory
April 18, 2022
The university not only weathered the COVID-19 pandemic, but also experienced significant growth over the last three years, said President William L. Henrich, MD, MACP, at the April 18 President’s Forum. It was the first forum held in person since the onset of the pandemic.
Graduating physical therapy student excited by the opportunity to help others live the lives they love
April 18, 2022
When Kevin Hamilton thinks about what’s next following his graduation from the Doctor of Physical Therapy program at the School of Health Professions this spring, he is struck by all the possibilities.
ASBMB Today: Sung takes over at San Antonio cancer institute
April 18, 2022
Dr. Patrick Sung, director of the Greehey Children’s Cancer Research Institute, was featured in this story from the American Society for Biochemistry and Molecular Biology. Read More
Houston Chronicle: UT Health (San Antonio), tech company partner to offer uninsured Texans free substance abuse treatment through app
April 18, 2022
Dr. Jennifer Potter, vice president for research and executive director of its Be Well Texas initiative, was quoted in this story. Read More
San Antonio Oral Cancer Walk 2022 set for April 23
April 15, 2022
The UT Health San Antonio School of Dentistry is partnering with The Oral Cancer Foundation to host The San Antonio Oral Cancer Walk 2022 on Saturday, April 23, celebrating oral cancer survivors and honoring those lost to the disease.
Team discovers novel drug target for Alzheimer’s and related dementias
April 14, 2022
Researchers from UT Health San Antonio today reported the discovery of a novel mechanism by which pathological forms of tau protein cause neurons to die. Alzheimer’s disease and chronic traumatic encephalopathy (CTE) are among more than 20 disorders that include tau protein pathology. The newly found mechanism of tau-induced damage can be altered pharmacologically, the scientists noted, making it a novel target for drug development.
Genetic Engineering & Biotechnology News: Alzheimer’s and Other Tauopathies May Depend on RNA Surveillance
April 14, 2022
MD-PhD student Gabrielle Zuniga, Dr. Bess Frost, Dr. Nicolas Musi and Dr. Sudha Seshadri, of the Barshop and Biggs Institutes, are quoted in this article. Read More
Fierce Biotech: Liver enzyme might hold the secret to new obesity treatments
April 14, 2022
Dr. Masahiro Morita of the Sam and Ann Barshop Institute and Department of Molecular Medicine; Dr. Sakie Katsumura, postdoctoral fellow in the Morita lab; and Dr. Nicolas Musi, director of the Barshop Institute and professor in the Department of Medici …
Team discovers novel root cause of tau-induced neurodegeneration
April 13, 2022
mRNA quality control identified as novel drug target for Alzheimer’s and related dementias Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (April 13, 2022) — Researchers from The University of Texas Health Science Center at San Ant …
San Antonio Report: BA.2 coronavirus subvariant detected in half of Bexar County cases
April 13, 2022
Dr. Marjorie David, Pathology and Laboratory Medicine, is quoted in this San Antonio Report article about the BA.2 variant in Bexar County and how UT Health San Antonio pathology lab is the only one in the county performing genome sequencing to determi …